US6359061008
US6359061008
National HealthCare Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.56B EUR | 3.31B EUR | 2.49B EUR | 2.13B EUR |
Enterprise Value | 3.35B EUR | 3.3B EUR | 2.45B EUR | 2.12B EUR |
Valuation Multiples | ||||
Trailing P/E | 25.55x | 23.6x | 20.15x | 24.26x |
Forward P/E | 528.16x | -- | -- | -- |
Price to Sales | 2.28x | 2.12x | 1.63x | 1.86x |
Price to Book | 3.17x | 2.95x | 2.28x | 1.99x |
EV/Revenue | 2.15x | 2.12x | 1.6x | 1.86x |
EV/EBITDA | 17.61x | 16.56x | 13.21x | 15.23x |
Price to FCF (P/FCF) | 56.31x | 22.59x | 14.8x | 18.44x |
EV/FCF | 53.09x | 22.54x | 14.53x | 18.39x |
FCF Yield | 1.78% | 4.43% | 6.76% | 5.42% |